[1]
Utkin, Y. Brain and quantum dots: Benefits of nanotechnology for healthy and diseased brain. Cent. Nerv. Syst. Agents Med. Chem., 2018, 18(3), 193-205.
[2]
Shelukhina, I.V.; Zhmak, M.N.; Lobanov, A.V.; Ivanov, I.A.; Garifulina, A.I.; Kravchenko, I.N.; Rasskazova, E.A.; Salmova, M.A.; Tukhovskaya, E.A.; Rykov, V.A.; Slashcheva, G.A.; Egorova, N.S.; Muzyka, I.S.; Tsetlin, V.I.; Utkin, Y.N. Azemiopsin, a selective peptide antagonist of muscle nicotinic acetylcholine receptor: Preclinical evaluation as a local muscle relaxant. Toxins (Basel), 2018, 10(1) pii: E34
[3]
Tran, T.V.; Hoang, A.N.; Nguyen, T.T.T.; Phung, T.V.; Nguyen, K.C.; Osipov, A.V.; Ivanov, I.A.; Tsetlin, V.I.; Utkin, Y.N. Anticoagulant activity of low-molecular weight compounds from heterometrus laoticus scorpion venom. Toxins (Basel), 2017, 9(11)pii: E343
[4]
Vulfius, C.A.; Kasheverov, I.E.; Kryukova, E.V.; Spirova, E.N.; Shelukhina, I.V.; Starkov, V.G.; Andreeva, T.V.; Faure, G.; Zouridakis, M.; Tsetlin, V.I.; Utkin, Y.N. Pancreatic and snake venom presynaptically active phospholipases A2 inhibit nicotinic acetylcholine receptors. PLoS One,, 2017, 12(10) e0186206. 10.1371/journal.pone.0186206. eCollection 2017.
[5]
Dubovskii, P.V.; Dubinnyi, M.A.; Volynsky, P.E.; Pustovalova, Y.E.; Konshina, A.G.; Utkin, Y.N.; Arseniev, A.S.; Efremov, R.G. Impact of membrane partitioning on the spatial structure of an S-type cobra cytotoxin. J. Biomol. Struct. Dyn., 2018, 36(13), 3463-3478.
[6]
Osipov, A.V.; Terpinskaya, T.I.; Kuznetsova, T.E.; Ryzhkovskaya, E.L.; Lukashevich, V.S.; Rudnichenko, J.A.; Ulashchyk, V.S.; Starkov, V.G.; Utkin, Y.N. Cobra venom factor and ketoprofen abolish the antitumor effect of nerve growth factor from cobra venom. Toxins (Basel), 2017, 9(9)pii: E274
[7]
Alekseeva, A.S.; Tretiakova, D.S.; Chernikov, V.P.; Utkin, Y.N.; Molotkovsky, J.G.; Vodovozova, E.L.; Boldyrev, I.A. Heterodimeric V. nikolskii phospholipases A2 induce aggregation of the lipid bilayer. Toxicon, 2017, 133, 169-179.
[8]
Utkin, Y.N. Modern trends in animal venom research - omics and nanomaterials. World J. Biol. Chem., 2017, 8(1), 4-12.
[9]
Utkin, Y.N.; Cherepakhin, I.Y.; Kryukova, E.V.; Shelukhina, I.V.; Makarova, Y.V.; Kasheverov, I.E.; Mukherjee, A.K.; Gusev, A.A.; Kuznetsov, D.V. Conjugates of α-Cobratoxin with CdSe quantum dots: Preparation and biological activity. Nano Hybrid. Compos. 13, 3-8.
[10]
Vulfius, C.A.; Spirova, E.N.; Serebryakova, M.V.; Shelukhina, I.V.; Kudryavtsev, D.S.; Kryukova, E.; Starkov, V.G.; Kopylova, N.V.; Zhmak, M.N.; Ivanov, I.A.; Kudryashova, K.S.; Andreeva, T.V.; Tsetlin, V.I.; Utkin, Y.N. Peptides from puff adder Bitis arietans venom, novel inhibitors of nicotinic acetylcholine receptors. Toxicon, 2016, 121, 70-76.
[11]
Kudryavtsev, D.S.; Shelukhina, I.V.; Son, L.V.; Ojomoko, L.O.; Kryukova, E.V.; Lyukmanova, E.N.; Zhmak, M.N.; Dolgikh, D.A.; Ivanov, I.A.; Kasheverov, I.E.; Starkov, V.G.; Ramerstorfer, J.; Sieghart, W.; Tsetlin, V.I.; Utkin, Y.N. Neurotoxins from snake venoms and α-conotoxin imi inhibit functionally active ionotropic γ-aminobutyric acid (GABA) receptors. J. Biol. Chem., 2015, 290(37), 22747-22758.
[12]
Kudryavtsev, D.; Shelukhina, I.; Vulfius, C.; Makarievam, T.; Stonik, V.; Zhmak, M.; Ivanov, I.; Kasheverov, I.; Utkin, Y.; Tsetlin, V. Natural compounds interacting with nicotinic acetylcholine receptors: From low-molecular weight ones to peptides and proteins. Toxins (Basel), 2015, 7(5), 1683-1701.
[13]
Utkin, Y.N. Animal venom studies: Current benefits and future developments. World J. Biol. Chem., 2015, 6(2), 28-33.
[14]
Dubovskii, P.V.; Utkin, Y.N. Antiproliferative activity of cobra venom cytotoxins. Curr. Top. Med. Chem., 2015, 15(7), 638-648.
[15]
Vulfius, C.A.; Kasheverov, I.E.; Starkov, V.G.; Osipov, A.V.; Andreeva, T.V.; Filkin, S.Y.; Gorbacheva, E.V.; Astashev, M.E.; Tsetlin, V.I.; Utkin, Y.N. Inhibition of nicotinic acetylcholine receptors, a novel facet in the pleiotropic activities of snake venom phospholipases A2. PLoS One, 2014, 9(12)e115428
[16]
Osipov, A.V.; Terpinskaya, T.I.; Kryukova, E.V.; Ulaschik, V.S.; Paulovets, L.V.; Petrova, E.A.; Blagun, E.V.; Starkov, V.G.; Utkin, Y.N. Nerve growth factor from cobra venom inhibits the growth of ehrlich tumor in mice. Toxins (Basel), 2014, 6(3), 784-795.
[17]
Utkin, Y.N. Three-finger toxins, a deadly weapon of elapid venom--milestones of discovery. Toxicon, 2013, 62, 50-55.
[18]
Utkin, Y.N.; Weise, C.; Kasheverov, I.E.; Andreeva, T.V.; Kryukova, E.V.; Zhmak, M.N.; Starkov, V.G.; Hoang, N.A.; Bertrand, D.; Ramerstorfer, J.; Sieghart, W.; Thompson, A.J.; Lummis, S.C.; Tsetlin, V.I. Azemiopsin from Azemiops feae Viper Venom, a Novel Polypeptide Ligand of Nicotinic Acetylcholine Receptor. J. Biol. Chem., 2012, 287(32), 27079-27086.
[19]
Osipov, A.V.; Rucktooa, P.; Kasheverov, I.E.; Filkin, S.Y.; Starkov, V.G.; Andreeva, T.V.; Sixma, T.K.; Bertrand, D.; Utkin, Y.N.; Tsetlin, V.I. Dimeric alpha-Cobratoxin X-ray Structure: Localization of intermolecular disulfides and possible mode of binding to nicotinic acetylcholine receptors. J. Biol. Chem., 2012, 287(9), 6725-6734.
[20]
Alama, A.; Bruzzo, C.; Cavalieri, Z.; Forlani, A.; Utkin, Y.; Casciano, I.; Romani, M. Inhibition of the nicotinic acetylcholine receptors by cobra venom alpha-neurotoxins: is there a perspective in lung cancer treatment? PLoS One, 2011, 6(6)e20695
[21]
Konshina, A.G.; Boldyrev, I.A.; Utkin, Y.N.; Omel’kov, A.V.; Efremov, R.G. Snake cytotoxins bind to membranes via interactions with phosphatidylserine head groups of lipids. PLoS One, 2011, 6(4)e19064
Related Books
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Frontiers in Clinical Drug Research-Dementia
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Article Metrics
4